+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 69 Actively Recruiting clinical trials

L

Actively Recruiting

Healthy Volunteer

This study evaluates whether a mobile phone-based mHealth Behavioural Change Communication BCC educational intervention can improve the adoption and exclusive use of Liquid Petroleum Gas LPG for cooking among households in semi-rural Bangladesh. Household air pollutants HAP from biomass fuels such as wood, agricultural residue, and cow dung expose almost 3 billion people worldwide, including 89% of people in Bangladesh. In the earlier GEOHealth study, 24 months of LPG use reduced personal PM2.5 exposure by about 58.2% and produced changes in innate immune and inflammatory responses, while chronic cardio-pulmonary markers remained relatively stable. More than 70% of households continued using LPG after the earlier study, although not exclusively. The investigators will conduct a large household-level randomized controlled trial using an mHealth-based educational intervention and will continue following the cohort. The study will examine the long-term effects of HAP reduction on subclinical measures of cardiovascular and pulmonary dysfunction, innate and inflammatory immune function, and antibody response to vaccines. Personal 24-hour and area-wise 5-day exposure to PM2.5 and black carbon will be repeatedly assessed before and after the intervention. Lung function and lung pathology will be assessed using spirometry, Chest X-ray, and high-resolution computed tomography of the chest. Cardiovascular measures will include blood pressure and EKG, while metabolic dysfunction will be assessed using HbA1c and fasting lipid profile. Immune function will be evaluated through immune cell phenotyping, functional cytotoxic killer cells, and oxidative stress of lymphocytes.

Age: 25Years - 70YearsFEMALEPhase Not Applicable
1 location
E

Actively Recruiting

Methanol poisoning is a serious health problem, especially in low- and middle-income countries, where outbreaks can cause severe harm to communities. Diagnosing methanol poisoning is difficult because its symptoms resemble other conditions, and traditional tests require costly laboratory equipment. This research aims to evaluate a new bedside test that uses a single drop of blood to detect formate, a substance only present in methanol poisoning, to improve diagnosis speed and accuracy. The research includes two parts first, an observational study comparing the new point-of-care formate test to standard laboratory tests to check its accuracy. If the new test shows good sensitivity, a second study will follow, which is a feasibility trial where hospitals are randomly assigned to different diagnostic approaches. This trial will investigate whether using the bedside test can lead to faster diagnosis and treatment, reduce unnecessary treatments, and evaluate clinical and cost outcomes. Participants suspected of methanol poisoning or unexplained metabolic acidosis at large hospitals in Bangladesh and India will be involved. During the studies, timing from patient arrival to diagnosis and treatment will be measured, along with clinical outcomes such as death rates and treatment needs. The research will also assess how well hospitals can be recruited for this type of trial and aims to raise awareness about methanol poisoning and improve care practices over the study period ending in 2028.

Age: 16Years +All Genders
6 locations
S

Actively Recruiting

Healthy Volunteer

Breast cancer is a common and potentially deadly disease that highlights the importance of early and accurate diagnosis to improve patient outcomes. Traditional diagnosis relies on manual examination of tissue samples under a microscope, which can be subjective and slow. This research aims to improve breast cancer diagnosis by using advanced computer techniques called deep learning to classify types of breast cancer from tissue images. The types include noninvasive cancers, confined within ducts or lobules, and invasive cancers that spread into surrounding tissue and make up about 70% of cases with generally worse outcomes. The study involves analyzing breast tissue samples collected through biopsy or mastectomy using histopathology, the current gold standard diagnostic method. Researchers will use deep learning models to classify the tissues as normal, benign, noninvasive in situ, or invasive cancer. This AI approach hopes to improve the accuracy and speed of diagnosis compared to manual methods. The model is designed to be adaptable to different healthcare settings, aiming to increase access to reliable breast cancer screening, especially in underserved or low-resource areas. Participants are women who have undergone biopsy due to suspected abnormal cell growth in the breast. Their tissue samples will be analyzed with the AI model within one week of biopsy or surgery. Researchers will assess the accuracy of the AI in classifying breast tissue types. The study focuses on improving cancer detection to support early treatment decisions and better outcomes. Participants may undergo biopsy and mastectomy procedures as part of their care, with histopathological analysis used for diagnosis. The study does not include follow-up screenings and excludes pregnant women and those with severe medical conditions that might affect results or safety.

All AgesFEMALE
1 location
I

Actively Recruiting

This trial focuses on low income rural Bangladeshi women with depression, studying whether combining poverty alleviation with depression treatment leads to better outcomes compared to depression treatment alone. The main questions include improvements in depression symptoms at six months, relapse rates at 18 months, and treatment uptake and retention. Additional outcomes studied include economic vulnerability, anxiety, culturally specific symptoms, quality of life, and functioning, with a mixed methods implementation evaluation involving interviews with participants and staff. Participants are assigned to one of two groups. The control group receives six sessions of a manualized group psychotherapy based on the WHO Problem Management Plus program, including problem solving, social support, behavioral activation, and relaxation techniques, along with four support group meetings. The experimental group receives the same psychotherapy plus a poverty alleviation program consisting of financial education sessions, savings accounts, consumption support for six months, a productive asset transfer of goats, animal feed and veterinary care for a year, gardening supplies, and agricultural skill building. Participants will take part in research interviews at 6, 12, and 18 months to assess depressive symptoms, relapse, economic status, anxiety, function, quality of life, and tension. The study monitors treatment adoption, retention, and fidelity through quantitative and qualitative methods. The total participation spans up to 18 months, allowing evaluation of both clinical and implementation outcomes.

Age: 18Years - 45YearsFEMALEPhase Not Applicable
1 location
R

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the effects of antibiotic treatment on asymptomatic bacteriuria AB during pregnancy in low- and middle-income countries. This phase 3 randomized controlled trial aims to reduce the incidence of small vulnerable newborns SVN and stillbirths SB, contributing to global health goals to prevent early childhood deaths. The study involves pregnant individuals and newborns across seven international sites collaborating with the NICHD Global Network for Womens and Childrens Health Research. Participants with AB are randomly assigned to one of two groups one group receives a 7-day course of oral nitrofurantoin monohydratemacrocrystals at 100 mg twice daily 14 doses total, while the other group receives a matching placebo on the same schedule. The study compares the impact of this antibiotic treatment versus placebo during pregnancy. During the study, participants will complete screening, randomization, treatment, and follow-up visits, with monitoring continuing until 42 days after birth. Researchers will assess the number of small vulnerable newborns or stillbirths as the main outcome. Participants must remain in the study area for the full postpartum follow-up period, during which health and safety are monitored carefully.

Age: 18Years - 49YearsFEMALEPhase 3
7 locations
C

Actively Recruiting

Researchers are studying women with polycystic ovary syndrome PCOS who are seeking to become pregnant. The study compares whether combining two drugs, cabergoline and letrozole, helps increase the rate of ovulation better than using letrozole alone. This randomized controlled trial involves participants diagnosed with PCOS according to the Rotterdam criteria and focuses on ovulation induction to improve fertility outcomes. Participants are randomly assigned to one of two groups. The experimental group takes cabergoline tablets twice on days 2 and 9 of their menstrual cycle plus letrozole tablets daily for five days starting on day 2. The comparison group takes only letrozole tablets daily for five days starting on day 2. Treatments continue for up to three menstrual cycles. Ovarian response is monitored using transvaginal ultrasound to check follicle growth on day 12 of each cycle. Participants will attend multiple visits each cycle for initial assessments, medication administration, ultrasound monitoring, and blood tests to confirm ovulation by measuring progesterone levels. Pregnancy testing and ultrasound for fetal heartbeat are done if menstruation is missed. The main outcome measured is ovulation rate within 21 days after each cycle, with additional monitoring of follicle size, ovulation confirmation, and pregnancy occurrence over 12 weeks.

Age: 18Years - 35YearsFEMALEPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are studying acute febrile illness in patients older than 28 days who live in rural areas of Laos, Myanmar, Thailand including the Thai-Myanmar border region, and Bangladesh. This observational study aims to describe the causes, clinical outcomes, and host biomarkers associated with these illnesses, which last 14 days or less. The study is part of a larger community-based network seeking to improve understanding and future interventions for febrile illness in low- and middle-income countries in South and Southeast Asia. The study involves two main parts Work Package A collects data from village health workers and local health facilities to understand the incidence and outcomes of febrile illness at the community level. Work Package B recruits patients seeking care at higher-level health facilities who may be more severely ill. In Work Package B, researchers collect various samples including venous blood and respiratory specimens for detailed diagnostic testing such as blood cultures, serological assays, molecular diagnostics, and host biomarker assays. Participants will be monitored for about one month to measure the prevalence of pathogens and recovery status. The study will analyze the association between host biomarkers and clinical outcomes to help create electronic decision-support tools for village health workers. These tools and other interventions will be tested later to improve assessment, triage, and treatment of patients with febrile illness. The total duration of participation and follow-up is approximately one month.

Age: 29Days +All Genders
4 locations
E

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the effectiveness of the Case Area Targeted Interventions CATI approach in reducing cholera incidence among household contacts and neighbors within cholera hotspots in Dhaka city. This study focuses on administering the Oral Cholera Vaccine OCV either as a single dose or two doses one month apart, targeting individuals aged 1 year and older who are not pregnant. The study also explores the genome analysis and immune response to V. cholerae antigens in different hotspots. Cholera cases are identified by rapid diagnostic tests among diarrheal patients at icddr,b Dhaka Hospital, and hotspots are defined as households within a 20-40 meter radius around the index cases. Participants are enrolled in clusters averaging 150 individuals per hotspot area on the same day as the index case identification. The intervention involves giving either one dose or two doses of OCV, with children under 5 years receiving two doses 14 days apart per WHO guidelines. Passive surveillance for cholera cases will be conducted through icddr,b hospital and other health facilities throughout the study. Data on individuals infection states, such as susceptible or infectious, will be tracked during a three-year follow-up period. During the trial, participants will be monitored through passive surveillance and data collection on cholera incidence. The primary outcome measured is the number of culture-confirmed V. cholerae cases from enrollment through the three-year follow-up. The study involves signed informed consent, and eligibility criteria include age, pregnancy status, and vaccination history. The trial aims to provide insights into the effectiveness of rapid targeted vaccination in reducing cholera transmission in endemic urban settings.

Age: 1Year +All GendersPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are evaluating the Cholera-Hospital-Based-Intervention-for-7-Days CHoBI7 Water, Sanitation, and Hygiene WASH Case Area Targeted Intervention CATI to reduce cholera infections and promote lasting WASH behaviors in areas near cholera cases in Bangladesh. Cholera causes millions of infections globally each year, and this study focuses on people living close to cholera patients who are at much higher risk during the first week after the patient receives care. The study aims to find scalable ways to deliver effective WASH interventions to these high-risk communities. The study involves three phases development and planning of the intervention using interviews and pilot testing, implementation and evaluation through a randomized controlled trial, and dissemination of findings for policy planning. Participants in the trial will be divided into two groups. One group receives the usual advice on oral rehydration and a WASH leaflet during a single visit. The other group participates in group sessions led by a health promoter who teaches about diarrhea spread, handwashing, water treatment, and safe water storage. These households also receive a cholera prevention package and weekly voice and text messages for 12 months promoting WASH behaviors. Water and clinical samples will be analyzed to study cholera transmission. Participants will be followed for one month to track new cholera infections and for 12 months to observe diarrhea cases and WASH behaviors. Data collected includes handwashing frequency, water quality, psychosocial factors, and child growth assessments. The study measures the number of cholera infections in the participant rings around cholera cases as the primary outcome. Safety monitoring and long-term follow-up are integrated throughout the trial, which is expected to provide important evidence on controlling cholera through targeted WASH interventions.

All AgesAll GendersPhase Not Applicable
2 locations
C

Actively Recruiting

Researchers are investigating whether Neurolytic Splanchnic Nerve Block NSNB reduces pain more effectively than Neurolytic Coeliac Plexus Block NCPB in adults with upper abdominal cancers such as pancreatic, gastric, hepatic, or biliary malignancies. This study also evaluates the safety profile of NSNB by monitoring adverse effects experienced by participants. The goal is to compare pain relief and side effects between these two nerve block procedures in patients reporting moderate to severe pain. Participants will be divided into two groups. One group will receive the Neurolytic Coeliac Plexus Block NCPB, which involves fluoroscopy-guided injection of local anesthetic and alcohol near the T12-L1 vertebrae to block nerve signals. The other group will receive the Neurolytic Splanchnic Nerve Block NSNB with a similar technique targeting the T11-T12 area and a slightly different alcohol volume. Both procedures are performed under fluoroscopic guidance with careful positioning and monitoring during and after the blocks. Throughout the study, participants will have their pain levels measured using the Visual Analog Scale VAS immediately after the procedure and at 7 days, 1 month, and 3 months. Quality of life will be assessed with a specialized questionnaire at 1 and 3 months. Opioid use will also be tracked to evaluate pain management needs. Participants are closely monitored for complications such as low blood pressure, diarrhea, pain in the back or shoulder, pneumothorax, or nerve-related changes immediately and up to three months after the procedure.

Age: 18Years +All GendersPhase Not Applicable
1 location

1-10 of 69

1